Home Excelencia Severo Ochoa
Genetic control of organ development and regeneration

Our work focuses on two areas: the role of transcription factors in cardiovascular development and regeneration, and the development of new genetic models to study the cellular basis of organ morphogenesis and regeneration.

In the first area, we have generated gain- and loss-of-function mouse models of the homeodomain trancription factors Meis and Pbx, revealing new roles for these factors in cardiovascular development. These studies have identified a new morphogenetic role for platelets during lymphangiogenesis, and further suggest a general role for platelets in vascular morphogenesis and remodeling that might be relevant to vascular disease. Our work on heart regeneration focuses on the epicardium, the outermost layer of the vertebrate heart, which plays an important role during cardiac development as a source of progenitor cells and signals controlling myocardial proliferation. A role for the epicardium in regeneration has also been suggested, but its exact function here is still unkown. Using the zebrafish model system we are analyzing the formation of the epicardium in vivo and generating tools to study the fate of epicardium derived cells and their role during cardiac regeneration.

We have developed two new strategies for analyzing morphogenesis. In one, an in vivo clonal analysis is being used to define cell lineage and topological relationships among cardiovascular lineages during embryonic development and adult homeostasis. The second strategy allows the generation of random genetic mosaics and has allowed us to demonstrate the role of cell competition in the early mouse embryo as a driving force for the maintenance of cell quality in stem cell pools; this work has been submitted for publication.

Regarding scientific networks, Miguel Torres is Chair of the Cost Action "HOX and TALE transcription factors in Development and Disease" and the group belongs to the RETICS TERCEL network.

Miguel Torres
  • Miguel Torres Sánchez
  • Associate Director
  • Ext.3107

Miguel Torres received his bachelor’s degree in Biology from the Universidad Complutense de Madrid in 1986, and was awarded his PhD in Biochemistry and Molecular Biology by the Universidad Autónoma de Madrid in 1991. The subject of his doctoral studies, carried out in Lucas Sánchez’s laboratory (CIB-CSIC), was the genetic study of early Drosophila development. During his postdoc with Peter Gruss at the Max Planck Institute for Biophysical Chemistry (Göttingen, Germany), Miguel’s use of directed mutations in mice made an important contribution to elucidating the multiple functions played by the pax gene family during embryonic development. In 1996, Miguel was awarded the title of CSIC Research Scientist at the Spanish National Center for Biotechnology (Centro Nacional de Biotecnología: CNB, Madrid), where he built an internationally recognized team specializing in the study of genetic mechanisms and cell signaling pathways implicated in vertebrate embryonic development. In 2004 he was named Head of the Department of Immunology and Oncology at the CNB, and in 2007 he moved his research group to the CNIC, where he took up the position of Head of the Department of Cardiovascular Developmental Biology, now the Department of Cardiovascular Development and Repair.

Since 2009, Miguel Torres has also occupied the post of Associate Director of the CNIC.